Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 41:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003776 AN006202 Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion Liver Mouse Environmental exposure University of Bonn LC-MS
ST003702 AN006074 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO Liver Mouse University of Bonn LC-MS
ST003614 AN005939 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion Liver Mouse University of Bonn LC-MS
ST003364 AN005512 Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease Aortic valve tissue Human Heart disease Technical University Dresden LC-MS
ST003220 AN005280 Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue Adipose tissue Mouse Obesity University of Utah LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
ST002093 AN003419 Lipidomics of High Fat vs Control Mice Lung Mouse Obesity University of North Carolina at Chapel Hill LC-MS
ST001859 AN003013 dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin Insect tissue Fruit fly VIB-KU Leuven MS(Dir. Inf.)
ST001859 AN003014 dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin Insect tissue Fruit fly VIB-KU Leuven MS(Dir. Inf.)
ST001738 AN002829 AdipoAtlas: A Reference Lipidome for Human White Adipose Tissue Adipose tissue Human Obesity University of Leipzig LC-MS
ST001442 AN002410 Human Optic Nerve Glaucoma and Control Lipidomes Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000917 AN001500 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001488 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
  logo